Skip to main content

Prime Capital Investment Advisors, LLC

Position in NVO — Novo Nordisk A S

CIK 1731446 OVERLAND PARK, KS

Position in NVO

as of Jun 30, 2026 · filed Aug 5, 2026
Position Value
$2,706,548
+$578,540 QoQ
Shares Held
56,457
-2.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#321
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Prime Capital Investment Advisors, LLC holds $167,982,283 across 14 Drug Manufacturers - General names. NVO ranks #7 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 NVO
Novo Nordisk A S
This page
56,457 $2,706,548

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,706,548 56,457
2026-03-31 $2,128,008 57,905
2025-12-31 $2,927,635 57,540
2025-09-30 $3,251,769 58,601
2025-06-30 $5,053,575 73,219
2025-03-31 $4,528,946 65,221
2024-12-31 $5,385,884 62,612
2024-09-30 $7,643,222 64,191
2024-06-30 $10,518,225 73,688
2024-03-31 $10,928,252 85,111
2023-12-31 $11,237,359 108,626
2023-09-30 $1,393,109 15,319
2023-06-30 $1,303,216 8,053
2023-03-31 $652,792 4,102
2022-12-31 $564,367 4,170
2022-09-30 $299,388 3,005
2022-06-30 $328,829 2,951
2022-03-31 $341,922 3,079
2021-12-31 $344,848 3,079
2021-09-30 $283,325 2,951
2021-06-30 $289,174 3,452
2021-03-31 $237,453 3,522
2020-12-31 $44,145 632
2020-09-30 $44,851 646
2020-06-30 $45,705 698
2020-03-31 $26,969 448